Ingrid K. Ruf

6.7k total citations · 3 hit papers
18 papers, 5.5k citations indexed

About

Ingrid K. Ruf is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Ingrid K. Ruf has authored 18 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Ingrid K. Ruf's work include Viral-associated cancers and disorders (14 papers), Lymphoma Diagnosis and Treatment (11 papers) and Eosinophilic Disorders and Syndromes (4 papers). Ingrid K. Ruf is often cited by papers focused on Viral-associated cancers and disorders (14 papers), Lymphoma Diagnosis and Treatment (11 papers) and Eosinophilic Disorders and Syndromes (4 papers). Ingrid K. Ruf collaborates with scholars based in United States, India and Bulgaria. Ingrid K. Ruf's co-authors include Muneesh Tewari, John R. Chevillet, Era L. Pogosova‐Agadjanyan, Jason D. Arroyo, Derek L. Stirewalt, Christopher F. Bennett, Jonathan F. Tait, Patrick S. Mitchell, Colin C. Pritchard and Donald Gibson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Ingrid K. Ruf

18 papers receiving 5.4k citations

Hit Papers

Argonaute2 complexes carry a population of circulating mi... 2011 2026 2016 2021 2011 2013 2014 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid K. Ruf United States 15 3.9k 3.1k 766 506 438 18 5.5k
James N. Higginbotham United States 26 4.8k 1.2× 2.6k 0.8× 719 0.9× 788 1.6× 471 1.1× 48 5.8k
Jeffrey L. Franklin United States 33 5.9k 1.5× 3.2k 1.0× 799 1.0× 912 1.8× 547 1.2× 66 7.0k
John R. Chevillet United States 13 4.1k 1.0× 3.3k 1.0× 325 0.4× 414 0.8× 569 1.3× 14 5.4k
Jie Ping United States 21 3.1k 0.8× 1.6k 0.5× 391 0.5× 475 0.9× 276 0.6× 56 3.8k
David G. Meckes United States 28 2.7k 0.7× 1.4k 0.4× 623 0.8× 632 1.2× 208 0.5× 54 3.7k
Zsuzsanna Tabi United Kingdom 31 3.6k 0.9× 2.0k 0.6× 854 1.1× 2.1k 4.1× 381 0.9× 53 5.5k
Charles A. Whittaker United States 37 3.3k 0.8× 1.1k 0.3× 1.3k 1.7× 630 1.2× 395 0.9× 72 6.0k
Philip H. Jones United Kingdom 38 4.4k 1.1× 2.0k 0.6× 1.9k 2.5× 593 1.2× 250 0.6× 96 8.6k
Zhen Lin United States 29 1.6k 0.4× 998 0.3× 994 1.3× 458 0.9× 331 0.8× 76 3.0k
Mercedes Tkach France 20 7.3k 1.9× 3.9k 1.2× 506 0.7× 1.6k 3.1× 763 1.7× 25 8.3k

Countries citing papers authored by Ingrid K. Ruf

Since Specialization
Citations

This map shows the geographic impact of Ingrid K. Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid K. Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid K. Ruf more than expected).

Fields of papers citing papers by Ingrid K. Ruf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid K. Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid K. Ruf. The network helps show where Ingrid K. Ruf may publish in the future.

Co-authorship network of co-authors of Ingrid K. Ruf

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid K. Ruf. A scholar is included among the top collaborators of Ingrid K. Ruf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid K. Ruf. Ingrid K. Ruf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chevillet, John R., Qing Kang, Ingrid K. Ruf, et al.. (2014). Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proceedings of the National Academy of Sciences. 111(41). 14888–14893. 883 indexed citations breakdown →
2.
Hindson, Christopher M., John R. Chevillet, Emily N. Gallichotte, et al.. (2013). Absolute quantification by droplet digital PCR versus analog real-time PCR. Nature Methods. 10(10). 1003–1005. 1153 indexed citations breakdown →
3.
Arroyo, Jason D., John R. Chevillet, Evan M. Kroh, et al.. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences. 108(12). 5003–5008. 2675 indexed citations breakdown →
4.
5.
Ruf, Ingrid K., et al.. (2009). Clusters of Basic Amino Acids Contribute to RNA Binding and Nucleolar Localization of Ribosomal Protein L22. PLoS ONE. 4(4). e5306–e5306. 23 indexed citations
6.
Ruf, Ingrid K., et al.. (2009). Growth-Promoting Properties of Epstein-Barr Virus EBER-1 RNA Correlate with Ribosomal Protein L22 Binding. Journal of Virology. 83(19). 9844–9853. 55 indexed citations
7.
Ruf, Ingrid K., et al.. (2005). Protection from Interferon-Induced Apoptosis by Epstein-Barr Virus Small RNAs Is Not Mediated by Inhibition of PKR. Journal of Virology. 79(23). 14562–14569. 49 indexed citations
8.
Zhao, Bo, Hua Jiang, Ingrid K. Ruf, et al.. (2003). Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses. Journal of Virology. 77(10). 5639–5648. 18 indexed citations
9.
Ruf, Ingrid K., Paul Rhyne, Hui-Jun Yang, et al.. (2001). EBV Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt’s Lymphoma. Current topics in microbiology and immunology. 153–160. 13 indexed citations
10.
Ruf, Ingrid K., Paul Rhyne, Chunying Yang, John L. Cleveland, & Jeffery T. Sample. (2000). Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis. Journal of Virology. 74(21). 10223–10228. 85 indexed citations
11.
Swart, Rachel, Ingrid K. Ruf, Jeffery T. Sample, & Richard Longnecker. (2000). Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway. Journal of Virology. 74(22). 10838–10845. 129 indexed citations
12.
Ruf, Ingrid K., Paul Rhyne, Hui Yang, et al.. (1999). Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma. Molecular and Cellular Biology. 19(3). 1651–1660. 101 indexed citations
13.
Ruf, Ingrid K. & Jeffery T. Sample. (1999). Repression of Epstein-Barr Virus EBNA-1 Gene Transcription by pRb during Restricted Latency. Journal of Virology. 73(10). 7943–7951. 14 indexed citations
14.
Ruf, Ingrid K., Amir Moghaddam, Fred Wang, & Jeffery T. Sample. (1999). Mechanisms That Regulate Epstein-Barr Virus EBNA-1 Gene Transcription during Restricted Latency Are Conserved among Lymphocryptoviruses of Old World Primates. Journal of Virology. 73(3). 1980–1989. 30 indexed citations
15.
Ruf, Ingrid K., et al.. (1997). The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element. Journal of Virology. 71(1). 354–361. 26 indexed citations
16.
Ruf, Ingrid K., et al.. (1997). Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma. Journal of Virology. 71(9). 6887–6897. 64 indexed citations
17.
Ruf, Ingrid K. & D R Rawlins. (1995). Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter. Journal of Virology. 69(12). 7648–7657. 27 indexed citations
18.
Ling, Paul D., et al.. (1994). EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Journal of Virology. 68(9). 5375–5383. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026